Physicians often tell AFib patients they should limit coffee consumption to protect their hearts. This new analysis, however, suggests that may not be necessary.
Researchers used AI-enabled software developed by Cleerly to evaluate the CCTA results of more than 6,000 patients. The software was consistently effective, identifying patients who may face an increased risk of poor outcomes.
Calcium in the coronary arteries is a known cardiac risk factor. However, new data suggest it may actually tell us more about a person's overall health than researchers previously believed.
Patients have typically been told to take aspirin and an oral anticoagulant following treatment to help combat the risk of blood clots. Now, they can skip the aspirin altogether.
Compared to standard hip-to-waist ratio measurements and BMI, the algorithm identifies significantly more instances of metabolic syndrome and its severity in individual patients.
New findings portray both treatment options in a similar light when it comes to overall survival rates, though one creates significantly more burden for both patients and hospital resources.
